Central Precocious Puberty and Response to GnRHa Therapy in Children with Cerebral Palsy and Moderate to Severe Motor Impairment: Data from a Longitudinal, Case-Control, Multicentre, Italian Study

Table 1

Baseline features of groups A, B, and C.

	Group A	Group B	Group C
Num. (F/M)	22 (18/4)	22 (17/5)	22 (22/0)
Baseline age (years) (mean ± SDS; range)	6.42 ± 1.74 (2.74–8.90)	6.63 ± 1.85 (2.10–9.70)	7.02 ± 0.79 (5.20–7.96)
Gestational age (weeks) (mean ± SDS)	36.93 ± 4.61	37.94 ± 4.11	39.33 ± 0.70
Apgar 1 min (mean ± SDS)°	4.58 ± 3.02	3.23 ± 2.24	9.01 ± 0.54
Apgar 5 min (mean ± SDS)°	6.25 ± 2.56	5.00 ± 1.80	9.50 ± 0.22
Birth weight (kg) (mean ± SDS)	2.65 ± 0.85	3.04 ± 0.84	3.33 ± 0.35°
GMFCS (III, IV, V) (%)	68, 27, 5	73, 18, 9	NA
Use of antiepileptic medication (%)	77%	100%	0%

°Significant difference between groups A and C.